Tevogen Bio Inc announced its 2026 Annual Meeting of Stockholders will be held virtually on August 24, 2026. Shareholders of record as of July 23, 2026, can vote and submit proposals by that date. The meeting is important for shareholder engagement and company governance, with deadlines set for submitting proposals and nominations. Tevogen focuses on making life-saving medicines more affordable and accessible through biotechnology, AI, and healthcare services integration.
Madonna returned to New York City to celebrate her No.1 album Confessions II with CLUB CONFESSIONS, a nightlife event co-hosted by MISTR that highlights dance music, queer culture, and HIV prevention. The event featured performances by Madonna and co...
Autonomix Medical has entered a warrant inducement agreement with an investor for the immediate exercise of outstanding warrants, raising approximately $2.6 million. The investor will purchase 428,731 shares at a reduced price of $6.00 per share. In ...
Edelson Lechtzin LLP is investigating Richemont for allegedly raising prices on luxury goods due to tariffs imposed under the Trump administration and failing to refund customers after the U.S. Supreme Court ruled those tariffs unlawful in February 2...
Binance's latest proof-of-reserves report shows customer Bitcoin holdings increased by 1.22% in June, adding 7,715 BTC to reach about 640,000 BTC. Meanwhile, Ethereum holdings fell by 1.41% and Tether balances dropped by 1.51%. These changes reflect ...
VEON Ltd.'s subsidiary Jazz International Holding Limited has acquired a 76.33% controlling stake in TPL Insurance Limited, a leading digital insurer in Pakistan, for about USD 16.4 million. This acquisition integrates insurance into VEON's digital e...
